J&J slides after jury orders it to pay $8 billion in male breast-growth case

A Philadelphia jury ruled Johnson & Johnson must pay $8 billion in damages to a man claiming the company didn’t properly warn male consumers its Risperdal drug could prompt breast growth.The company’s stock fell as much as 1.5% on Wednesday following the Tuesday decision.The case, brought by Nicholas Murray, is one of 13,400 Risperdal-related lawsuits, according to J&J’s latest SEC filings.Watch J&J trade live here.A Philadelphia jury ordered Johnson & Johnson to pay $8 billion in damages to a man claiming the company didn’t warn male consumers its Risperdal drug could result in breast growth.J&J fell as much as 1.5% in early Wednesday trading following the Tuesday decision. The case, brought forth by Nicholas Murray, is one of 13,400 lawsuits related to Risperdal, according to the company’s

Main Source
Author

You might also like More from author

Comments are closed.